Results

1–3 of 3 results for disease management

The Impact of Good Days' Underfunding on Retinal Disease Management Insights From a National Survey of American Society of Retina Specialists Members
Michael M. Lai, MD, PhD
Annual Meeting Talks
2025
Effects of Time Since Diagnosis to Intravitreal Aflibercept Injection and Baseline BCVA on Outcomes in CRVO: Post Hoc Analysis of the COPERNICUS and GALILEO Trials
Dilsher S. Dhoot, MD
Annual Meeting Talks
2022
Characteristics and Outcomes of nAMD Patients Managed in US Routine Clinical Practice: Analysis of the IRIS Registry Database
Anita Barikian, MD
Annual Meeting Talks
2022